Silvia Nicolini

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

Lisa Bodei, Mark Kidd, Irvin Modlin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 141 citations

Tumor Biology, Oncology, Engineering +14

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Maddalena Sansovini, Stefano Severi, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 117 citations

Medicine, Neuroendocrine Disorder, Endocrinology +4

Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET

Annarita Ianniello, Maddalena Sansovini, Stefano Severi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 100 citations · Full text

Prognostic Role, Medicine, Radionuclide Therapy +13

Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

Silvia Nicolini, Stefano Severi, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 78 citations

Neuro-oncology, Engineering, Radiation Therapy +11

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

Stefano Severi, Maddalena Sansovini, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 68 citations

Immunology, Treatment Option, Pharmacotherapy +2